RSPR Pharma AB Report issue

For profit Phase 2
Founded: Uppsala Sweden (2006)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2011
NCT01354184
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

pemirolast (alamast) (6 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aneurysm (Phase 2)

Aortic Aneurysm (Phase 2)

Aortic Aneurysm, Abdominal (Phase 2)

Asthma (Phase 2)

Muscular Dystrophies (Phase 2)

Muscular Dystrophy, Duchenne (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 1